Connect with us

Hi, what are you looking for?

Health

New Clinical Guideline on Radiation Therapy for IDH-mutant Glioma

A new clinical guideline from the American Society for Radiation Oncology (ASTRO) provides recommendations on the use of radiation therapy to treat patients with isocitrate dehydrogenase (IDH)-mutant grade 2 and grade 3 diffuse glioma. Evidence-based recommendations outline the multidisciplinary planning and delivery techniques to manage this subset of central nervous system (CNS) tumors. The guideline, ASTRO’s first for lower-grade glioma, is published in Practical Radiation Oncology.

Click to comment

Leave a Reply

Your email address will not be published.

You May Also Like

CHMO.com